“The Essential Medicinal Chemistry of Curcumin”

Conclusion: all my neighbors have dogs. Of course, you’d say that’s ridiculous. And you would be right. You can’t just consider the specific trials that support your theory. This means that if you are making sweeping statements about curcumin, it is indeed NOT “beyond the scope” of your work to look at ALL the trials that have results. But that is what  seems to have occurred here. Note: the review authors tell us that they chose these trials because the data is available on the clinicaltrials.gov website. Um, I’d like to point out that there are curcumin clinical trial results in PubMed, too… Let’s look at their first choice, which I thought was quite interesting for a variety of reasons, as we will see: The goal of a recent University of Rochester study testing curcumin on breast cancer patients undergoing radiotherapy was to reduce radiation-caused dermatitis. Its results, the review authors say, are “inconclusive.” I looked up the results on the clinical trial website (as far as I know, and as far as the review authors know, the results have not been published anywhere else yet), and yes, true, there was not much difference between the Mean Radiation Dermatitis Severity Scores of the two groups: 2.02 in the curcumin group, 1.99 in the placebo group. However, I didn’t stop there. I found a previous University of Rochester clinical trial, in which curcumin was tested on a group of breast cancer patients. Same group of researchers, same cen...
Source: Margaret's Corner - Category: Cancer & Oncology Authors: Tags: Blogroll curcumin Source Type: blogs